Engineered immune cells targeted and reduced the toxic protein plaques that drive Alzheimer’s disease in a recent study.
Experts say 2026 could be a crucial year for drug patents, with the likely emergence of fresh disputes over follow-on patents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results